Clinical trial
The Utility of FDG-PET for Radiation Treatment in NSCLC
NCT00385164 · AHS Cancer Control Alberta, Other · Unknown status
Key facts
| NCT number | NCT00385164 |
|---|---|
| Title | The Utility of FDG-PET for Radiation Treatment in NSCLC |
| Official title | The Utility of 18-Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) for Radiation Treatment Planning in Non-Small Cell Lung Cancer (NSCLC) |
| Lead sponsor | AHS Cancer Control Alberta, Other |
| Collaborators | Calgary Health Region |
| Status | Unknown status |
| Study type | Observational |
| Conditions | Lung Neoplasms, Positron Emission Tomography |
| Intervention type | Procedure |
| Interventions | PET/CT scan for RT planning |
| Enrollment | 50 |
| Start date | Oct 1, 2006 |
| First posted | Oct 6, 2006 |
| Last update posted | Jul 25, 2017 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: